gamithromycin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
antibiotics, produced by Streptomyces strains 5548 145435-72-9

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • gamithromycin
  • zactran
  • ML-1709460
  • ML-460
An antibiotic used in cattle
  • Molecular weight: 777.05
  • Formula: C40H76N2O12
  • CLOGP: 2.94
  • LIPINSKI: 2
  • HAC: 14
  • HDO: 5
  • TPSA: 180.08
  • ALOGS: -3.42
  • ROTB: 9

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
azlogd74 LogD at pH 7.4 0.222 High 0.80
caco2-efflux Caco-2 efflux ratio (BA/AB) 34.995 High 0.80
caco2-intrinsic-papp Caco-2 intrinsic apparent permeability 0.299 10^-6 cm/s High 0.80
dh-clint Dog hepatocyte intrinsic clearance 1.514 uL/min/10^6 cells High 0.80
dppb Dog plasma protein binding (% unbound) 72.450 % High 0.80
fcs-ppb Fetal calf serum protein binding (% unbound) 61.150 % High 0.80
herg hERG pIC50 4.103 pIC50 High 0.80
hh-clint Human hepatocyte intrinsic clearance 0.931 uL/min/10^6 cells High 0.80
hlm-clint Human liver microsomal intrinsic clearance 4.753 uL/min/mg protein High 0.80
hppb Human plasma protein binding (% unbound) 78.790 % High 0.80
mdck-mdr1-bcrp-efflux MDCK-MDR1-BCRP efflux ratio 2.339 High 0.80
mdck-mdr1-efflux MDCK-MDR1 efflux ratio 3.412 High 0.80
mh-clint Mouse hepatocyte intrinsic clearance 1.858 High 0.80
mppb Mouse plasma protein binding (% unbound) 75.300 High 0.80
nih-mdck-mdr1-efflux NIH MDCK-MDR1 efflux ratio 3.221 High 0.80
pfas-class PFAS structural alert (1 = True, 0 = False) 0
pld-class Phospholipidosis risk class (1 = positive, 0 = negative) 1 High 0.80
pppb Pig plasma protein binding (% unbound) 78.680 % High 0.80
rat-kpuu-brain Rat brain Kpuu 0.013 % High 0.80
rh-clint Rat hepatocyte intrinsic clearance 1.294 uL/min/10^6 cells High 0.80
rh-fuinc Rat hepatocyte fraction unbound in incubation 80.580 % High 0.80
rppb Rat plasma protein binding (% unbound) 75.760 % High 0.80
solubility-dd Solubility at pH 7.4 in DMSO 851.138 uM High 0.80

Approvals:

DateAgencyCompanyOrphan
None FDA

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
MeSH PA D000890 Anti-Infective Agents
MeSH PA D000900 Anti-Bacterial Agents
CHEBI has role CHEBI:36047 antibacterial drug
CHEBI has role CHEBI:48001 protein synthesis inhibitor

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

SpeciesUseRelation
Cattle Bovine respiratory disease (BRD) associated with Mannheimia haemolytica Indication
Cattle Bovine respiratory disease (BRD) associated with Pasteurella multocida Indication
Cattle Bovine respiratory disease (BRD) associated with Histophilus somni Indication
Cattle Bovine respiratory disease (BRD) associated with Mycoplasma bovis Indication

🐶 Veterinary products

ProductApplicantIngredients
Zactran Boehringer lngelheim Animal Health USA Inc. 1

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
CHEBI:195437 CHEBI
CHEMBL2107342 ChEMBL_ID
C552399 MESH_SUPPLEMENTAL_RECORD_UI
13688 IUPHAR_LIGAND_ID
DB11416 DRUGBANK_ID
C2975314 UMLSCUI
8754 INN_ID
D06598 KEGG_DRUG
59364992 PUBCHEM_CID
ZE856183S0 UNII
1113697 RXNORM

Pharmaceutical products:

None